A Randomized Controlled Trial of a VR Social Music-Movement Exergame for Depression and Anxiety i… (NCT07482852) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
A Randomized Controlled Trial of a VR Social Music-Movement Exergame for Depression and Anxiety in Young Adults
130 participantsStarted 2026-04-01
Plain-language summary
This randomized controlled trial aims to evaluate the effectiveness of a virtual reality (VR) music-movement exergaming intervention for improving social connectedness and psychological well-being among young adults. Participants will be randomly assigned to one of three groups: (1) a VR social music-movement exergame group, (2) a VR solo exergame group without social interaction, and (3) a waitlist control group. The intervention integrates rhythmic movement, music-based interaction, and immersive VR environments to promote engagement and social connection. Primary outcomes include changes in depressive symptoms, anxiety, and social connectedness. Secondary outcomes include psychological need satisfaction and physical fitness indicators. Assessments will be conducted at baseline, post-intervention, and follow-up. The study will provide evidence on the potential benefits of immersive VR-based exergaming interventions for mental health and social well-being in young adults.
Who can participate
Age range
18 Years – 25 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Aged 18 to 25 years
* Meeting criteria for mild to moderate depression (BDI-II score 14-28) or anxiety (BAI score 8-25)
* Able to understand the study procedures and provide informed consent
* Willing to participate in the VR intervention and complete all assessments
Exclusion Criteria:
* Diagnosis of severe mental illness (e.g., psychosis or severe psychiatric disorders)
* Severe motion sickness or intolerance to virtual reality
* Currently receiving structured psychotherapy or psychological intervention
* Any medical condition that would prevent safe participation in moderate physical activity
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in depression symptoms measured by the Beck Depression Inventory-II (BDI-II)
Timeframe: Baseline (Week 0) to Post-intervention (Week 6)
2
Change in anxiety symptoms measured by the Beck Anxiety Inventory (BAI)
Timeframe: Baseline (Week 0) to Post-intervention (Week 6)
Trial details
NCT IDNCT07482852
SponsorHunan University of Traditional Chinese Medicine